Investigation of suppression of the hypothalamic-pituitary-gonadal axis to restore spermatogenesis in azoospermic men treated for childhood cancer.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Human Reproduction

• Publication date

  2002-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HUMREP/17.7.1715PMID 12093829
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Failure to preserve fertility in patients with Hodgkin's disease

  2004influential reference
• Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.

  2002cited by this paper
• Testicular changes during infantile 'quiescence' in the marmoset and their gonadotrophin dependence: a model for investigating susceptibility of the prepubertal human testis to cancer therapy?

  2002cited by this paper
• Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study.

  2002cited by this paper
• MAGE‐A4, a germ cell specific marker, is expressed differentially in testicular tumors

  2001cited by this paper
• Infancy is not a quiescent period of testicular development.

  2001cited by this paper
• Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistent azoospermia postchemotherapy

  2001cited by this paper
• Serum inhibin B levels in males with gonadal dysfunction.

  2000cited by this paper
• Subfertility following treatment for childhood cancer.

  2000cited by this paper
• Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats.

  2000cited by this paper
• Regulation of inhibin production in the human male and its clinical applications.

  2000cited by this paper
• World Health Organization Laboratory Manual for the Examination of Human Semen and Sperm‐Cervical Mucus Interaction, 4th ed.

  2000cited by this paper
• Undetectable inhibin B serum levels in men after testicular irradiation.

  1999cited by this paper
• Hormonal treatment after cytotoxic therapy stimulates recovery of spermatogenesis.

  1999cited by this paper
• Inhibin B in seminal plasma: testicular origin and relationship to spermatogenesis.

  1998cited by this paper
• Gonadal damage from chemotherapy and radiotherapy.

  1998cited by this paper
• Hormonal stimulation of the recovery of spermatogenesis following chemo‐ or radiotherapy

  1998cited by this paper
• Use of Testosterone To Prevent Cyclophosphamide-Induced Azoospermia

  1997cited by this paper
• Hormone treatment after irradiation stimulates recovery of rat spermatogenesis from surviving spermatogonia.

  1997influential reference
• Testicular Androgen Receptor Protein: Distribution and Control of Expression

  1996influential reference
• Measurement of dimeric inhibin B throughout the human menstrual cycle.

  1996influential reference
• Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease

  1996cited by this paper
• Gonadal function following chemotherapy for childhood Hodgkin's disease.

  1996cited by this paper
• Cellular and Molecular Regulation of Testicular Cells

  1996cited by this paper
• Protection against procarbazine-induced testicular damage by GnRH-agonist and antiandrogen treatment in the rat.

  1995cited by this paper
• Hormonal protection from cyclophosphamide-induced inactivation of rat stem spermatogonia.

  1995influential reference
• Follicle-stimulating hormone (FSH) escape during chronic gonadotropin-releasing hormone (GnRH) agonist and testosterone treatment.

  1994cited by this paper
• Protection from radiation-induced damage to spermatogenesis by hormone treatment.

  1994cited by this paper
• Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas.

  1993cited by this paper
• Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.

  1992cited by this paper
• Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia.

  1991cited by this paper
• Protective effect of medroxyprogesterone acetate plus testosterone against radiation-induced damage to the reproductive function of male rats and their offspring.

  1991cited by this paper
• Testicular dysfunction after cyclophosphamide‐vincristine‐procarbazine‐prednisolone chemotherapy for advanced hodgkin's disease a long‐term follow‐up study

  1990cited by this paper
• The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence

  1990cited by this paper
• Protection by steroid contraceptives against procarbazine-induced sterility and genotoxicity in male rats.

  1990cited by this paper
• Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.

  1990influential reference
• Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.

  1988influential reference
• Protection from procarbazine-induced damage of spermatogenesis in the rat by androgen.

  1986influential reference
• Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations.

  1985influential reference
• Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.

  1985cited by this paper
• Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.

  1984cited by this paper
• Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death.

  1983cited by this paper
• Gonadal function after combination chemotherapy for Hodgkin's disease in childhood.

  1982cited by this paper
• :A long term follow-up study

  1982cited by this paper
• CYCLICAL COMBINATION CHEMOTHERAPY AND GONADAL FUNCTION: Retrospective Study in Males

  1979cited by this paper
• CYCLICAL COMBINATION CHEMOTHERAPY AND GONADAL FUNCTION

  1979cited by this paper
• Cyclical combination chemotherapy and gonadal function. Retrospective study in males.

  1979cited by this paper
• Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.

  1976cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Different Roles of Prepubertal and Postpubertal Germ Cells and Sertoli Cells in the Regulation of Serum

  year unknowncited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Androgen Receptor Distribution in Adult Human Testis*

  year unknowncited by this paper

• Effect of Exogenous Medications and Anabolic Steroids on Male Reproductive and Sexual Health

  2020cites this paper
• Fertility Preservation in Patients with Hematologic Malignancies and Recipients of Hematopoietic Cell Transplants.

  2019cites this paper
• Cancer and Sperm DNA Damage

  2018cites this paper
• Effect of chemotherapy on the prepubertal testis

  2016cites this paper
• Influence radio and chemotherapy cancer patients to development of male infertility (literature review).

  2016cites this paper
• Protective effect of N-Acetylcysteine (NAC) on human spermatozoa exposed to etoposide, a chemotherapeutic agent

  2015cites this paper
• Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents.

  2015cites this paper
• Protective effect of N - acetylcysteine (NAC) on human spermatozoa exposed to etoposide, a chemotherapeutic agent

  2015cites this paper
• Fertility preservation for boys and adolescents facing sterilizing medical therapy

  2014cites this paper
• The effect of melatonin on procarbazine induced testicular toxicity on rats

  2014cites this paper
• Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation

  2013cites this paper
• Gold nanoparticles elevate plasma testosterone levels in male mice without affecting fertility.

  2013cites this paper
• Fertility Preservation in Males

  2012cites this paper
• Approach to Fertility Preservation in Adult and Pre-pubertal Males

  2012cites this paper
• Exogenous Medication or Substance-Induced Factors

  2012cites this paper
• Cancer in Males: Implications for Sperm Quality, Fertility, and Progeny Outcome

  2011cites this paper
• Hormonal suppression for fertility preservation in the male

  2011cites this paper
• Regenerative Potential of Spermatogenesis after Gonadotoxic Therapies

  2011cites this paper
• Male germline stem cells : developmental and regenerative potential

  2011cites this paper
• [Preservation of fertility in case of sterilizing treatment].

  2010cites this paper
• Sposoby zapobiegania niepłodności u chorych leczonych z powodu nowotworów

  2010cites this paper
• The impact of lymphoma and treatment on male fertility

  2010cites this paper
• Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers

  2008cites this paper
• Focus on Fertility Preservation Hormonal suppression for fertility preservation in males and females

  2008influential citation
• Cancer survivors and infertility: a review of a new problem and novel answers.

  2006cites this paper
• Progress in the development of childhood cancer therapy.

  2006cites this paper
• Gonadal damage and options for fertility preservation in female and male cancer survivors.

  2006cites this paper
• American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.

  2006cites this paper
• Fertility Preservation Before Therapy for Cancer New Perspectives

  2006cites this paper
• Evaluación de la pubertad y la función gonadal en pacientes pediátricos supervivientes de un cáncer infantil

  2005cites this paper
• Preserving Fertility After Cancer

  2005cites this paper
• Subfertility in children and young people treated for solid and haematological malignancies

  2005cites this paper
• Sertoli Cell Endocrinology and Signal Transduction: Androgen Regulation

  2005cites this paper
• Hormonal approaches to preservation and restoration of male fertility after cancer treatment.

  2005cites this paper
• Fertility preservation for young patients with cancer: who is at risk and what can be offered?

  2005cites this paper
• Strategies for Preventing Chemotherapy- and Radiotherapy-Induced Gonadal Damage

  2004cites this paper
• Effects of medroxyprogesterone and estradiol on the recovery of spermatogenesis in irradiated rats.

  2004cites this paper
• Obesity and gynaecologic issues in teenagers Related review: Body morphology and its impact on adolescent and pediatric gynecology, with a special emphasis on polycystic ovary syndrome

  2003cites this paper
• Preservation of fertility in children treated for cancer

  2003cites this paper
• Inhibition of spermatogonial differentiation by testosterone.

  2003cites this paper
• The present and future state of hormonal treatment for male infertility.

  2003cites this paper
• Male fertility following childhood cancer: current concepts and future therapies.

  2003cites this paper
• Suppression of testosterone stimulates recovery of spermatogenesis after cancer treatment.

  2003cites this paper
• Late reproductive sequelae following treatment of childhood cancer and options for fertility preservation.

  2002cites this paper
• Faculdade de Medicina da Universidade do Porto

  2001cites this paper